Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Douer

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Human Gene Therapy|March 20, 1996
High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: use of marker genes to investigate hematopoietic reconstitution in adultsD Douer, A Levine, W F Anderson, et al.
Cancer|June 1, 1988
Recombinant interferon alpha-C for advanced hairy cell leukemia. An Israeli multicenter studyD Aderka, R Michalevicz, Y Daniel, et al.
The American Journal of Medicine|December 1, 1981
High-dose combined-modality therapy and autologous bone marrow transplantation in resistant cancerD Douer, R E Champlin, W G Ho, et al.
Annals of Internal Medicine|October 6, 1997
Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphomaE Zuckerman, T Zuckerman, A M Levine, et al.
Bone Marrow Transplantation|March 15, 2016
Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullaryJ M Watts, X V Wang, R T Swords, et al.
Bone Marrow Transplantation|April 19, 2016
Autologous transplant remains the preferred therapy for relapsed APL in CR2C Ganzel, V Mathews, K Alimoghaddam, et al.
Bone Marrow Transplantation|May 22, 2024
Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trialsC Ganzel, Y Wang, K Roopcharan, et al.
Bone Marrow Transplantation|July 18, 2024
Correction: Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trialsC Ganzel, Y Wang, K Roopcharan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemiaS L Soignet, S R Frankel, D Douer, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Human Gene Therapy|March 20, 1996
High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: use of marker genes to investigate hematopoietic reconstitution in adultsD Douer, A Levine, W F Anderson, et al.
Cancer|June 1, 1988
Recombinant interferon alpha-C for advanced hairy cell leukemia. An Israeli multicenter studyD Aderka, R Michalevicz, Y Daniel, et al.
The American Journal of Medicine|December 1, 1981
High-dose combined-modality therapy and autologous bone marrow transplantation in resistant cancerD Douer, R E Champlin, W G Ho, et al.
Annals of Internal Medicine|October 6, 1997
Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphomaE Zuckerman, T Zuckerman, A M Levine, et al.
Bone Marrow Transplantation|March 15, 2016
Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullaryJ M Watts, X V Wang, R T Swords, et al.
Bone Marrow Transplantation|April 19, 2016
Autologous transplant remains the preferred therapy for relapsed APL in CR2C Ganzel, V Mathews, K Alimoghaddam, et al.
Bone Marrow Transplantation|May 22, 2024
Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trialsC Ganzel, Y Wang, K Roopcharan, et al.
Bone Marrow Transplantation|July 18, 2024
Correction: Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trialsC Ganzel, Y Wang, K Roopcharan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemiaS L Soignet, S R Frankel, D Douer, et al.
Pageof 10